Gary L. Buchschacher

4.6k citations
42 papers · 1.2k indexed · 1 hit paper · h-index 17
Topics
Virus-based gene therapy research (11 papers)CRISPR and Genetic Engineering (9 papers)HIV Research and Treatment (6 papers)
Partner nations
United StatesJapanSpain

In The Last Decade

Gary L. Buchschacher

42 papers receiving 1.2k citations

Hit Papers

Atezolizumab with enzalutamide versus enzalutamide alone ...2022202620232024202250100150

Peers

Gary L. Buchschacher
Comparison fields: 5 of 80
  • Molecular Biology 588
  • Genetics 370
  • Oncology 348
  • Virology 342
  • Pulmonary and Respiratory Medicine 254
Replace Edward J. Dunphy with:
Edward J. Dunphy United States
Y. Ramanathan United States
Lela Lackey United States
Dorothy L. Buchhagen United States
M Kuppuswamy United States
Alagarsamy Srinivasan United States
Misako Yajima Japan
Fuh-Mei Duh United States
Christophe Demaison France
Gary L. Buchschacher relative to Edward J. Dunphy United States Edward J. Dunphy's profile →
Citations per field
00.5×7.3×
Edward J. Dunphy · 1×
Citations per year

Countries citing papers authored by Gary L. Buchschacher

Since Specialization
Citations

This map shows the geographic impact of Gary L. Buchschacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Buchschacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Buchschacher more than expected).

Fields of papers citing papers by Gary L. Buchschacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Buchschacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Buchschacher. The network helps show where Gary L. Buchschacher may publish in the future.

Co-authorship network of co-authors of Gary L. Buchschacher

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. Buchschacher. A scholar is included among the top collaborators of Gary L. Buchschacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. Buchschacher. Gary L. Buchschacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 4
3 3
4 19
5 1
6
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialbreakdown →
157
7 6
8 4
9 2
10 22
11 6
12 6
13 17
14 1
15 30
16 33
17 9
18 18
19 27
20 12

About Gary L. Buchschacher

Gary L. Buchschacher is a scholar working on Virology, Otorhinolaryngology and Oncology, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (9 papers) and HIV Research and Treatment (6 papers). The work is most often cited by research in Virology (342 citations), Genetics (370 citations) and Oncology (348 citations). Gary L. Buchschacher has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Antonito T. Panganiban, Flossie Wong‐Staal, Eric O. Freed, Eric Delwart, Christopher J. Sweeney, Nobuaki Matsubara, Sanjeev Mariathasan, Jennifer Doss, Charles G. Drake and Patrick Williams. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026